Definition of ubiquitination modulator COP1 as a novel therapeutic target in human hepatocellular carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Hepatocellular carcinoma (HCC) targeted therapy development is challenging.
• COP1, a ubiquitination modulator, is overexpressed in HCC and regulates p53.
• COP1's role in HCC progression necessitates further investigation.

Purpose of the Study:

• To investigate the therapeutic potential of COP1 blockade using short interfering RNA (siRNA) in HCC.
• To determine the efficacy of COP1 inhibition on HCC cell growth and apoptosis.
• To explore the molecular mechanisms underlying COP1 blockade's effects in HCC.

Main Methods:

• Utilized siRNA to inhibit COP1 expression in various HCC cell lines.
• Assessed cell growth inhibition and apoptosis induction.
• Performed microarray expression analysis to identify molecular alterations.
• Evaluated systemic delivery of COP1 siRNA in an orthotopic mouse xenograft model.

Main Results:

• COP1 isoform COP1-1 was identified as an effective siRNA target for HCC growth inhibition and apoptosis.
• Growth inhibition was observed in HCC cells with wild-type or mutant p53, but not in p53-null cells.
• COP1 blockade induced a p53-associated molecular network, driving antiproliferative effects.
• Systemic delivery of COP1 siRNA suppressed liver tumor growth in mice without adverse immune responses.

Conclusions:

• COP1 blockade via siRNA is a viable strategy for inhibiting HCC progression.
• COP1 is a promising molecular target for developing novel systemic therapies for HCC.
• The findings provide a proof of principle for COP1-targeted HCC treatment.